Hello, you are using an old browser that's unsafe and no longer supported. Please consider updating your browser to a newer version, or downloading a modern browser.
Hello, you are using an old browser that's unsafe and no longer supported. Please consider updating your browser to a newer version, or downloading a modern browser.
Patrick Lindsay serves as President & CEO of UBC, guiding the company’s mission, vision, values, and strategic imperatives. He is responsible for clinical operations, business growth strategy, sales and marketing, and acquisition support.
Patrick served as one of the early developers of the organization, which grew out of a passion for innovation and commitment to working with pharmaceutical and biotech organizations in providing safety, efficacy, and value of pharmaceutical and medical products.
Patrick has been a leader in the healthcare and pharmaceutical services industry for more than 25 years. During his career, Mr. Lindsay has held senior management positions in such diverse areas as clinical stage operations, data management, biostatistics, information technology, marketing, and business development.
He earned his Bachelor of Science in management from Rosemont College in Pennsylvania. Patrick is unconditionally focused on establishing high-level customer relationships and partnering with customers to match UBC service offerings to their research development projects, from both strategic and execution perspectives.
Patrick was featured on the cover of the December 2013 edition of Pharmaceutical Executive: Pharma’s Life Partner: An Interview with United BioSource’s Patrick Lindsay.
President & CEO
Serving as UBC’s Senior Vice President & Head of Patient Support Services, Nicole Hebbert is responsible for all Patient Support Services within UBC. Nicole leads the Operational Excellence, Client Satisfaction, Patient Engagement and Program Delivery teams. Nicole’s responsibilities extend externally to our client relationships – where, she is responsible for our consulting initiatives surrounding a specialty product’s market entry and supply chain considerations. These considerations include wholesale and/or distribution approaches for drug delivery that optimize not only the commercial goals for the brand, but, is also informed by the site of care, coverage dynamics of the product, as well as prescriber and patient-centered needs for access to therapy with positive outcomes.
With over 25 years leading Specialty Pharmacy and Pharma Services teams, Nicole brings forward a unique perspective and experience set to solving today’s patient services challenges. Focused on transformative and technology-enabled solutions, her strategic engagement model provides consultative and meaningful solutions to all phases of specialty drug commercialization. Nicole’s ‘high tech’ and ‘high touch’ model of designing, implementing, and operating her programs make her a strong business partner to our clients, and, a strong leader.
Equally committed to employees and patients, Nicole is responsible for the operational health of all Patient Support Services programs at UBC. Using qualitative and quantitative measures, she believes in the constant evolution of services. As payer, privacy, and regulatory shifts demand early insights and prospective solutions, the dynamic challenges of access, affordability, and adherence are untangled by Nicole and her team.
Nicole has previously served as Vice President, Pharmacy Operations at Priority Health, where she launched some of the industry’s earliest reimbursement hubs and patient support programs for Aetna Specialty Pharmacy and Walmart Specialty. She subsequently spent 9 years in a variety of operational and strategic roles, with increasing responsibility, supporting Express Scripts integrations of Wellpoint and Medco specialty operations. Nicole joined UBC’s leadership team in 2014.
SVP & Head of Patient Services
Brett Huselton serves as Senior Vice President & Chief Business Officer at UBC. Brett joined UBC in 2008 and has greater than 20 years in the pharmaceutical services industry from early development through late phase development, globally – supporting strategy and business development growth strategies across clinical and late stage, through commercially optimized launch strategies.
In this role, Brett is responsible for Sales, Marketing, Business Strategy, Product Development, Proposal Development, Pricing and Connected Healthcare Technologies, as well as Analytics and Insights. Brett is responsible to align UBC’s deep bench of expertise, product and service solutions to address the development, safety, access, affordability and value demands facing our clients as they navigate regulatory, payer, physician and patient demands for a successful initial and ongoing experience with their therapy.
Brett and his teams focus on a deep understanding of the market, regulatory and legislative initiatives, payer and managed market demands to ensure our proposed solutions address the specific demands of our clients – whether in the pre-market setting, as they capture evidence of efficacy, effectiveness and safe use – all the way through supporting their approach to entering the market, establishing an ideal patient access, affordability or clinical coordination program to ensure access to and success on our customers therapy.
Importantly – as the market dynamics change, Brett’s teams are focused heavily on trends that impact the efficiency of the delivery of work, or, impact the evidence generation strategies required to meet both clinical and commercial objectives as our clients define their ideal product label and target market.
Brett and UBC focus on making meaningful decisions related to impacting the transformation and advancement of patient care through investing in new approaches, tools, data standards and technologies that can streamline acquisition of key data (endpoints), take advantage of advancements in the interoperability between systems being promoted externally across health systems, payers, data providers and pharma – as well as modeling and following the patient journey from clinical research encounters through to commercial care to truly point the market to a more value-driven conversation about a product’s safe use, patient-specific benefit, humanistic & clinical value proposition of the data across both individual Patients and larger real-world populations.
SVP & Chief Business Officer
Dr. Annette Stemhagen is an epidemiologist with more than 30 years of public health research experience, including 20 years in safety surveillance of pharmaceutical, biotechnology, and vaccine products. She is the Senior Vice President of Safety, Epidemiology, Registries and Risk Management within United BioSource, where she provides strategic consultative services to pharmaceutical, biotech, and medical device clients.
Dr. Stemhagen has specific expertise in safety surveillance and design, implementation, and analysis of epidemiologic studies, registries, large streamlined safety studies, and actual use and observational studies for products in Phase IIIb and post approval. She has designed and evaluated risk assessment studies, including more than 50 regulatory-mandated, long-term global safety studies. She has designed risk intervention programs, risk management evaluation studies, Risk Minimization Action Plans (RiskMAPs), Risk Evaluation and Mitigation Strategies (REMS), and risk minimization programs for EU Risk Management Plans for more than 120 products.
Dr. Stemhagen is active in the International Society for Pharmacoepidemiology and the Drug Information Association. She served on the Board of Directors for each of these organizations. Dr. Stemhagen has held adjunct faculty appointments at the University of Pennsylvania Center for Epidemiology and Biostatistics in the School of Medicine, the Temple University School of Pharmacy, and the Drexel University School of Public Health. In 2004, Dr. Stemhagen was appointed as the first Industry Representative to the FDA Drug Safety and Risk Management Advisory Committee.
SVP & Chief Scientific Officer
Mrs. O’Donnell leads the UBC REMS SERRM team that develops REMS strategies, develops REMS and REMS Supporting Documents and leads the REMS evaluations.
Mrs. O’Donnell’s background includes more than 20 years of healthcare and clinical research experience and has worked in the area of Risk Management for the last 10 years. Her career began as a registered nurse in the hospital setting where she was responsible for medical surgical patients, pediatric patients, and was a certified oncology nurse. Mrs. O’Donnell’s also spent 2 years as Acute Dialysis nurse, providing renal care to the critically ill. She began in clinical research as a drug safety associate focusing on medical and legal review of medical charts. Then she spent several years in Strategic Research & Marketing where she researched and evaluated the drug development pipeline for major pharmaceutical and biotech companies for a large contract research organization, assisted in the writing and coordination of government proposals, and was responsible for global information requests.
During her tenure she was awarded the Strategic Research and Marketing award.
During her time at UBC Mrs. O’Donnell has overseen pregnancy registries, investigator-initiated studies, and minority focused phase IV trials. While in Program Management, she provided support and direction to UBC project teams conducting late stage studies, including regulatory mandated programs and observational studies.
As the Corporate Vice President, REMS, Safety and Strategic Engagement, she is responsible for UBC Pharmacovigilance, designs REMS, REMS Supporting Documents, REMS tools and oversees the team responsible for REMS effectiveness assessments as well as REM’s FDA Assessment Reports. She ensures quality and performance expectations are being met, including responsibility for detailed timeline development and maintenance, budget management, regulatory requirements, and study start-up and operations
Mrs. O’Donnell received her Bachelor’s of Science in Nursing from the former College Misericordia (currently Misericordia University) in northeastern Pennsylvania followed by her Program Management Certificate from Villanova University, also in Pennsylvania.
Corporate VP, REMS, Safety, and Strategic Engagement
Rich Hamel serves as Senior Vice President & Chief Financial Officer and leads UBC’s team responsible for the growth and development of the UBC finance organization which includes all functions to support the ongoing operations of the company as well as our new contract wins, new customers and existing business.
He brings to this role more than 25 years of experience in international finance, focused primarily in the life sciences, biotech, and pharmaceutical sector. His experience includes finance and controller responsibilities for public and private organizations, at both the operational and corporate level. In addition, Rich has extensive experience of successful merger and acquisition transactions on both the buying and selling side, and demonstrated success of integrating acquired companies.
A graduate of York University in Toronto, Ontario, Rich received his MBA from Union College in Schenectady, New York. Most recently, Rich served at inVentiv Health as the Vice President of Finance and Assistant Treasurer.
SVP & CFO
A.K. Gupta serves as Senior Vice President & Chief Information Officer where his team is focused on creating technologies that automate, drive operational efficiency, and introduce technology product capabilities in the areas of cognitive processing, intelligent systems, data and mobility.
He brings to this role more than 20 years of health care experience in technology, product development, pharmacy operations, and pharma services. Throughout his career, his work has focused on the intersection of technology, business processes, and organizational transformation. In addition, A.K. has worked across a variety of computing environments ranging from large-scale enterprise technology development to extreme transaction processing environments to expert knowledge-based systems that leveraged ontologies, inference, and AI. He served as Vice President of Technology at Accredo where he was responsible for all aspects of technology transformation strategy focused on the patient and physician experience.
A.K. is committed to collaborating with UBC’s senior management team on demonstrating value to patients, UBC’s clients, the organization and its employees by operating on a foundation built on trust, integrity, and a shared vision.
SVP & CIO
Lakshana serves as Senior Vice President & Chief Human Resources Officer where her team focuses on development and implementation of a human resources strategy that supports the overall business goals geared toward accelerated growth.
She brings to this role more than 20 years of human resources experience. She served as Senior Vice President, Business Transformation and Human Resources for DFC Global Corporation in Malvern, Pennsylvania. In that role, she successfully executed a full-scale RFP to select a systems vendor and implementation partner. She also completed the proposal, design and testing phases of the product platform upgrade and spearheaded a company wide process mapping exercise to create detailed process maps and diagnostics on the “as-is” state of each department, published maps, and shared a gaps register for each area.
She used her expertise to build centers of excellence in core human resources areas such as human resources strategy and policy, total rewards, payroll and benefits, human resources systems and automation, in order to support the growth and expansion in North America and Europe.
Lakshana holds a BS in Hospitality Management from Temple University and a B. Com from the University of Delhi.
SVP & CHRO
Aaron Berger serves as the Head of Global Late Stage Services for UBC. In this role, he works towards the strategic design and execution of late stage clinical trials and observational research that will generate powerful, real world evidence of product effectiveness, safety, and value.
Aaron joined the UBC team in 2003 and has since served in a range of diverse roles leveraging global capabilities in the execution of peri- and post-marketing product development programs and real world evidence generation. He has supported the development of RWD / RWE architectures and solutions to drive greater insight into the safety profile and value proposition of medicines.
Head of Global Late Stage Services
Richard Miller is the Vice President, Global Quality Compliance for UBC. He is responsible for the company’s global Quality Management System. Richard has more than 20 years working in the pharmaceutical, biotech, and medical device industries.
Prior to joining UBC in January 2022, Richard was with eResearchTechnology, Inc. (ERT) where, as part of the executive management team, he helped drive substantial growth for the company through a series of mergers and acquisitions, service line expansions, and proprietary development and deployment of regulatory-compliant technology solutions. Prior to ERT, Richard worked for Atlantic Richfield’s (ARCO) Chemical division in environmental health and safety as a research scientist.
Richard earned his B.S. in Environmental Science from Drexel University in Philadelphia. He lives in the Philadelphia suburbs, spending time between the Philadelphia area and the southern Delaware beaches. He enjoys hiking with his bloodhounds, mountain biking, and the east coast surf.
VP, Global Quality Compliance